secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alphatec Holdings, Inc. (ATEC)
CIK:        0001350653
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009910
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ATEC prelim FY2025 rev ~$764M (+25%), FY2026 outlook $890M; acquires OsteoAdapt distribution rights
--------------------------------------------------------------------------------

- Preliminary FY2025 total revenue ~$764M (25% growth); surgical revenue grew 26% with volume up 24%.
- FY2025 adjusted EBITDA reaffirmed at $91M; cash balance ~$161M; Q4 free cash flow expected $6-8M.
- FY2026 outlook: total revenue $890M (17% growth), adjusted EBITDA ~$130M, positive free cash flow ~$20M.
- Acquired exclusive U.S. distribution rights for Theradaptive's OsteoAdapt (rhBMP-2 biologic, Phase II for spinal fusion).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1350653/000119312526009910/0001193125-26-009910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1350653/000119312526009910/atec-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer